Clinical Trial Update: Predictors of Response to Iron and Erythropoietin Stimulating Agents [Phase 4]

View source ↗

Summary

Phase 4 trial investigating predictors of response to iron and erythropoietin stimulating agents in patients with chronic renal failure and anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Renal Failure

Snippet

Sponsor: Imperial College London | Conditions: Renal Failure Chronic, Anemia | Phase 4 | Status: COMPLETED | Results posted: 2019-07-05